Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C44H88O2 |
| Molecular Weight | 649.1683 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCCCCCC
InChI
InChIKey=NJIMZDGGLTUCPX-UHFFFAOYSA-N
InChI=1S/C44H88O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-43-46-44(45)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-43H2,1-2H3
| Molecular Formula | C44H88O2 |
| Molecular Weight | 649.1683 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:50:50 GMT 2025
by
admin
on
Mon Mar 31 19:50:50 GMT 2025
|
| Record UNII |
K8NU647RJ0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
K8NU647RJ0
Created by
admin on Mon Mar 31 19:50:50 GMT 2025 , Edited by admin on Mon Mar 31 19:50:50 GMT 2025
|
PRIMARY | |||
|
241-646-5
Created by
admin on Mon Mar 31 19:50:50 GMT 2025 , Edited by admin on Mon Mar 31 19:50:50 GMT 2025
|
PRIMARY | |||
|
17671-27-1
Created by
admin on Mon Mar 31 19:50:50 GMT 2025 , Edited by admin on Mon Mar 31 19:50:50 GMT 2025
|
PRIMARY | |||
|
DTXSID0066242
Created by
admin on Mon Mar 31 19:50:50 GMT 2025 , Edited by admin on Mon Mar 31 19:50:50 GMT 2025
|
PRIMARY | |||
|
87221
Created by
admin on Mon Mar 31 19:50:50 GMT 2025 , Edited by admin on Mon Mar 31 19:50:50 GMT 2025
|
PRIMARY | |||
|
K8NU647RJ0
Created by
admin on Mon Mar 31 19:50:50 GMT 2025 , Edited by admin on Mon Mar 31 19:50:50 GMT 2025
|
PRIMARY | |||
|
1312543
Created by
admin on Mon Mar 31 19:50:50 GMT 2025 , Edited by admin on Mon Mar 31 19:50:50 GMT 2025
|
PRIMARY | RxNorm |